CSIMarket
 


Galecto Inc   (GLTO)
Other Ticker:  
 

Galecto Inc 's Leverage Ratio

GLTO's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -16.13% Galecto Inc improved Leverage Ratio in third quarter 2023 to 0.34, above the Galecto Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 215 other companies have achieved lower Leverage Ratio than Galecto Inc in the III Quarter 2023. While Leverage Ratio total ranking has improved so far in the third quarter 2023 to 783, from total ranking in the second quarter 2023 at 805 .

Explain Leverage Ratio?
Who are GLTO Customers?
What are GLTO´s Total Liabilities?


GLTO Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -48.6 % -48.63 % -50.32 % -47.32 % -43.89 %
Y / Y Total Liabilities Change 36.23 % 93.8 % 87.72 % 129.07 % 48.67 %
Leverage Ratio MRQ 0.34 0.35 0.28 0.19 0.13
GLTO's Total Ranking # 783 # 805 # 708 # 462 # 337
Seq. Equity Change -14.46 % -13.18 % -18.49 % -15.09 % -14.5 %
Seq. Total Liabilities Change -16.13 % 5.64 % 25.03 % 22.98 % 19.31 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 216
Healthcare Sector # 373
Overall Market # 783


Leverage Ratio Statistics
High Average Low
0.35 0.14 0.04
(Jun 30 2023)   (Dec 31 2020)




Financial Statements
Galecto Inc 's Equity $ 37 Millions Visit GLTO's Balance sheet
Galecto Inc 's Total Liabilities $ 13 Millions Visit GLTO's Balance sheet
Source of GLTO's Sales Visit GLTO's Sales by Geography


Cumulative Galecto Inc 's Leverage Ratio

GLTO's Leverage Ratio for the trailling 12 Months

GLTO Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -48.6 % -48.63 % -50.32 % -47.32 % -43.89 %
Y / Y Total Liabilities TTM Growth 36.23 % 93.8 % 87.72 % 129.07 % 48.67 %
Leverage Ratio TTM 0.28 0.22 0.16 0.11 0.08
Total Ranking TTM # 415 # 2 # 3 # 1 # 164
Seq. Equity TTM Growth -14.46 % -13.18 % -18.49 % -15.09 % -14.5 %
Seq. Total Liabilities TTM Growth -16.13 % 5.64 % 25.03 % 22.98 % 19.31 %


On the trailing twelve months basis Despite of the repayements of liabilities of -16.13% in the trailing twelve months ending in III Quarter 2023, Leverage Ratio improved to 0.28, above Galecto Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 118, during the past 12 months, other companies have achieved lower Leverage Ratio than Galecto Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 2 to 415.

Explain Leverage Ratio?
Who are GLTO Customers?
What are GLTO´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 119
Healthcare Sector # 220
Within the Market # 415


trailing twelve months Leverage Ratio Statistics
High Average Low
0.84 0.27 0.04
(Dec 31 2020)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Spero Therapeutics Inc   0.92 $ 49.276  Millions$ 53.705  Millions
Unity Biotechnology Inc   0.91 $ 33.064  Millions$ 36.206  Millions
Kiora Pharmaceuticals Inc  0.87 $ 7.085  Millions$ 8.104  Millions
Igm Biosciences Inc   0.87 $ 220.488  Millions$ 253.862  Millions
Eton Pharmaceuticals Inc   0.87 $ 14.634  Millions$ 16.892  Millions
Verastem inc   0.86 $ 71.814  Millions$ 83.180  Millions
Onconova Therapeutics inc   0.86 $ 12.521  Millions$ 14.517  Millions
Cryoport inc   0.86 $ 463.128  Millions$ 537.528  Millions
Pulmatrix Inc   0.85 $ 16.889  Millions$ 19.881  Millions
Pacira Biosciences inc   0.85 $ 702.911  Millions$ 831.551  Millions
Aptevo Therapeutics Inc   0.84 $ 12.411  Millions$ 14.718  Millions
Roivant Sciences Ltd   0.84 $ 1,117.009  Millions$ 1,325.633  Millions
Avadel Pharmaceuticals Plc  0.84 $ 92.035  Millions$ 110.149  Millions
Novabay Pharmaceuticals Inc   0.83 $ 5.815  Millions$ 7.037  Millions
Acurx Pharmaceuticals inc   0.82 $ 3.223  Millions$ 3.935  Millions
First Wave Biopharma Inc   0.81 $ 2.648  Millions$ 3.279  Millions
Rhythm Pharmaceuticals inc   0.79 $ 156.725  Millions$ 197.474  Millions
Geovax Labs Inc   0.78 $ 7.082  Millions$ 9.119  Millions
Abvc Biopharma Inc   0.77 $ 6.985  Millions$ 9.062  Millions
Innoviva Inc   0.77 $ 481.901  Millions$ 627.493  Millions
Neximmune Inc   0.76 $ 6.308  Millions$ 8.254  Millions
Cartesian Therapeutics Inc   0.76 $ 45.705  Millions$ 60.329  Millions
Macrogenics Inc   0.75 $ 145.992  Millions$ 193.980  Millions
Acadia Pharmaceuticals Inc   0.75 $ 270.366  Millions$ 362.174  Millions
Hutchmed china Limited  0.74 $ 549.232  Millions$ 743.387  Millions
Gain Therapeutics inc  0.71 $ 5.182  Millions$ 7.331  Millions
Vyne Therapeutics Inc   0.67 $ 7.762  Millions$ 11.505  Millions
Guardion Health Sciences Inc   0.67 $ 5.176  Millions$ 7.702  Millions
Organogenesis Holdings Inc   0.67 $ 185.782  Millions$ 276.865  Millions
Vincerx Pharma Inc   0.67 $ 10.535  Millions$ 15.741  Millions

Date modified: 2023-11-07T13:18:12+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com